Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5089180016 | Product containing precisely delafloxacin (as delafloxacin meglumine) 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5089181017 | Delafloxacin (as delafloxacin meglumine) 300 mg powder for solution for infusion vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely delafloxacin (as delafloxacin meglumine) 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Is a | Delafloxacin only product in parenteral dose form | true | Inferred relationship | Some | ||
| Product containing precisely delafloxacin (as delafloxacin meglumine) 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Has manufactured dose form | Powder for conventional release solution for infusion (dose form) | true | Inferred relationship | Some | ||
| Product containing precisely delafloxacin (as delafloxacin meglumine) 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Has unit of presentation | Vial (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely delafloxacin (as delafloxacin meglumine) 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some | ||
| Product containing precisely delafloxacin (as delafloxacin meglumine) 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Has precise active ingredient | Delafloxacin meglumine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely delafloxacin (as delafloxacin meglumine) 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Has basis of strength substance (attribute) | Delafloxacin (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely delafloxacin (as delafloxacin meglumine) 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely delafloxacin (as delafloxacin meglumine) 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR